13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002032331
Total reported value
$459.0M
$459.0M
81 檔
11.3%
As reported in its official Q1 2026 Form 13F filing, Arrowpoint Investment Partners's tracked investment portfolio stood at $459.0M with 81 total positions.
In Q1 2026, Arrowpoint Investment Partners adopted a defensive or profit-taking posture, trimming 19 positions and completely liquidating 61 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IGV | Ishares Expanded Tech-softwa | ETF-Tech | 16.42% | -14.84% | — | |
| 2 | KWEB | Kranesh Csi China Internet | ETF-Emerging Markets | 10.12% | -10.12% | EXIT | |
| 3 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 7.96% | -5.27% | +2123.36% | |
| 4 | SMH | Vaneck Semiconductor ETF | ETF-Other | 7.49% | +3.94% | — | |
| 5 | EWZ | Ishares Msci Brazil ETF | ETF-Other | 4.09% | -4.09% | EXIT | |
| 6 | ASX | Ase Technology Holding -adr | Stock-Tech | 3.46% | -3.46% | EXIT | |
| 7 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 2.60% | -2.39% | +55.85% | |
| 8 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 2.52% | -1.91% | +512.91% | |
| 9 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 2.46% | -1.72% | +677.30% | |
| 10 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 2.45% | -2.11% | — | |
| 11 | ASND | Ascendis Pharma A/S | Stock-Other | 2.40% | -2.40% | EXIT | |
| 12 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 2.40% | -1.74% | +329.76% | |
| 13 | PFE | Pfizer Inc | Stock-Healthcare | 1.78% | -1.78% | EXIT | |
| 14 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.72% | -1.72% | EXIT | |
| 15 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.72% | -1.72% | EXIT | |
| 16 | AMGN | Amgen Inc | Stock-Healthcare | 1.54% | -1.54% | EXIT | |
| 17 | GILD | Gilead Sciences Inc | Stock-Healthcare | 1.48% | -1.48% | EXIT | |
| 18 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.35% | -1.35% | EXIT | |
| 19 | MCHP 0.75 06-01-30Bond | Microchip Technology Inc | Bond | 1.32% | -1.32% | EXIT | |
| 20 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.25% | -0.56% | — | |
| 21 | PRAX | Praxis Precision Medicines I | Stock-Other | 1.10% | -0.92% | +85.16% | |
| 22 | INSM | Insmed Inc | Stock-Healthcare | 1.02% | -0.32% | -39.27% | |
| 23 | PTGX | Protagonist Therapeutics Inc | Stock-Other | 0.87% | -0.78% | — | |
| 24 | BLTE | Belite Bio Inc - Adr | Stock-Other | 0.85% | -0.78% | +96.92% | |
| 25 | EWT | Ishares Msci Taiwan ETF | ETF-Other | 0.79% | +2.12% | — | |
| 26 | MRNA | Moderna Inc | Stock-Healthcare | 0.77% | -0.54% | — | |
| 27 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 0.77% | -0.77% | EXIT | |
| 28 | BIIB | Biogen Inc | Stock-Healthcare | 0.77% | -0.45% | +64.83% | |
| 29 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.69% | -0.08% | -83.10% | |
| 30 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 0.69% | -0.44% | +149.09% | |
| 31 | XLU | St Sr Utl Sl Se Spdr Etf-usd | ETF-Other | 0.67% | -0.46% | -68.28% | |
| 32 | OSG | Octave Specialty Group Inc | Stock-Other | 0.58% | -0.58% | EXIT | |
| 33 | TWST | Twist Bioscience CORP | Stock-Other | 0.57% | -0.12% | +34.87% | |
| 34 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.55% | +0.14% | +221.29% | |
| 35 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 0.55% | -0.39% | — | |
| 36 | BNTX | Biontech Se-adr | Stock-Other | 0.54% | -0.39% | — | |
| 37 | NTRA | Natera Inc | Stock-Healthcare | 0.53% | -0.36% | — | |
| 38 | AXGN | Axogen Inc | Stock-Other | 0.48% | -0.48% | EXIT | |
| 39 | XLI | Ss Industrial Select Sector | ETF-Other | 0.47% | -0.45% | +17.86% | |
| 40 | COGT | Cogent Biosciences Inc | Stock-Other | 0.47% | -0.39% | +87.46% | |
| 41 | XLE | Ss Energy Select Sector | ETF-Other | 0.46% | -0.46% | EXIT | |
| 42 | XLP | Ss Consumer Staples Sel Sect | ETF-Other | 0.46% | -0.45% | — | |
| 43 | CYTK | Cytokinetics Inc | Stock-Healthcare | 0.43% | -0.27% | +64.91% | |
| 44 | GMAB | Genmab A/s -sp Adr | Stock-Other | 0.38% | -0.38% | EXIT | |
| 45 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 0.38% | -0.16% | +97.78% | |
| 46 | TNGX | Tango Therapeutics Inc | Stock-Other | 0.38% | -0.33% | — | |
| 47 | COO | Cooper Cos Inc/the | Stock-Healthcare | 0.37% | +0.17% | -43.49% | |
| 48 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.36% | +0.31% | -95.19% | |
| 49 | ERAS | Erasca Inc | Stock-Other | 0.36% | -0.36% | EXIT | |
| 50 | LITE | Lumentum Holdings Inc | Stock-Tech | 0.35% | -0.35% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | KWEB | Kranesh Csi China Internet | +9.7% | +431.03% | Add |
| 2 | GOOGL | Alphabet Inc-cl A | +7.9% | +2123.36% | Add |
| 3 | NBIX | Neurocrine Biosciences Inc | +2.5% | +512.91% | Add |
| 4 | AXSM | Axsome Therapeutics Inc | +2.4% | +677.30% | Add |
| 5 | ASND | Ascendis Pharma A/S | +2.3% | +294.66% | Add |
| 6 | IONS | Ionis Pharmaceuticals Inc | +2.3% | +55.85% | Add |
| 7 | PTCT | Ptc Therapeutics Inc | +2.3% | +329.76% | Add |
| 8 | PFE | Pfizer Inc | +1.6% | +64.54% | Add |
| 9 | REGN | Regeneron Pharmaceuticals | +1.6% | +62.68% | Add |
| 10 | AMGN | Amgen Inc | +1.3% | -17.20% | Trim |
| 11 | GILD | Gilead Sciences Inc | +1.1% | -38.41% | Trim |
| 12 | VRTX | Vertex Pharmaceuticals Inc | +1.1% | +1.43% | Add |
| 13 | PRAX | Praxis Precision Medicines I | +1% | +85.16% | Add |
| 14 | BLTE | Belite Bio Inc - Adr | +0.8% | +96.92% | Add |
| 15 | INSM | Insmed Inc | +0.7% | -39.27% | Trim |
| 16 | BIIB | Biogen Inc | +0.7% | +64.83% | Add |
| 17 | RVMD | Revolution Medicines Inc | +0.7% | +149.09% | Add |
| 18 | MDGL | Madrigal Pharmaceuticals Inc | +0.5% | +221.29% | Add |
| 19 | TWST | Twist Bioscience CORP | +0.5% | +34.87% | Add |
| 20 | XLE | Ss Energy Select Sector | +0.5% | +372.22% | Add |
| 21 | COGT | Cogent Biosciences Inc | +0.4% | +87.46% | Add |
| 22 | XLI | Ss Industrial Select Sector | +0.4% | +17.86% | Add |
| 23 | CYTK | Cytokinetics Inc | +0.4% | +64.91% | Add |
| 24 | AXGN | Axogen Inc | +0.4% | -15.25% | Trim |
| 25 | OSG | Octave Specialty Group Inc | +0.4% | -31.45% | Trim |
| 26 | BBIO | Bridgebio Pharma Inc | +0.4% | +97.78% | Add |
| 27 | XLU | St Sr Utl Sl Se Spdr Etf-usd | +0.3% | -68.28% | Trim |
| 28 | COO | Cooper Cos Inc/the | +0.2% | -43.49% | Trim |
| 29 | DYN | Dyne Therapeutics Inc | +0.2% | +19.68% | Add |
| 30 | APGE | Apogee Therapeutics Inc | +0.2% | -36.64% | Trim |
| 31 | SYRE | Spyre Therapeutics Inc | +0.2% | -55.26% | Trim |
| 32 | GMAB | Genmab A/s -sp Adr | +0.2% | -62.92% | Trim |
| 33 | NVST | Envista Holdings CORP | +0.2% | -38.77% | Trim |
| 34 | NKTR | Nektar Therapeutics | +0.2% | -42.56% | Trim |
| 35 | XLF | Ss Financial Select Sector | +0.1% | -73.50% | Trim |
| 36 | GDX | Vaneck Gold Miners ETF | +0.1% | -67.74% | Trim |
| 37 | GOOG | Alphabet Inc-cl C | +0.1% | +50.00% | Add |
| 38 | INDA | Ishares Msci India ETF | 0% | — | Unchanged |
| 39 | TEVA | Teva Pharmaceutical-sp Adr | 0% | -83.10% | Trim |
| 40 | XLK | Ss Technology Select Sector | -0.2% | -97.89% | Trim |
| 41 | LITE | Lumentum Holdings Inc | -0.3% | -95.11% | Trim |
| 42 | LLY | Eli Lilly & Co | -1.1% | -95.19% | Trim |
| 43 | JNJ | Johnson & Johnson | -7.9% | -97.48% | Trim |
| 44 | NVDA | Nvidia CORP | — | EXIT | Sold out |
| 45 | MSFT | Microsoft CORP | — | EXIT | Sold out |
| 46 | C | Citigroup Inc | — | EXIT | Sold out |
| 47 | HD | Home Depot Inc | — | EXIT | Sold out |
| 48 | QCOM | Qualcomm Inc | — | EXIT | Sold out |
| 49 | PLTR | Palantir Technologies Inc-a | — | EXIT | Sold out |
| 50 | RSP | Invesco S&p 500 Equal Weight | — | EXIT | Sold out |
According to official SEC Form 13F filings, Arrowpoint Investment Partners reported a total U.S. public equity portfolio value of $459.0M across 81 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IGV, KWEB, GOOGL) accounted for 11.3% of total reported equity market value during Q1 2026.
Top New Position Initiated
IGV
市值: $18.5M
Top Position Liquidated / Trimmed
NVDA
前期市值: $82.5M
During Q1 2026, Arrowpoint Investment Partners's top holdings by market value included IGV (16.4%)、KWEB (10.1%)、GOOGL (8.0%). The largest single position, IGV, represented 16.4% of total portfolio value.
In Q1 2026, Arrowpoint Investment Partners made 141 total portfolio adjustments, initiating 38 new buys, adding to 23 positions, trimming 19 holdings, and fully liquidating 61 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.